New: Robolist and YAS partner on robotics insurance
Skip to content

Wandercraft

Paris, FranceFounded 2012Late stage

RoboScore

58.8

Out of 100. Its robots, plus proof from customers and the press.

5 of 6 measures have data

News bonus

5.0

From the last 90 days, up to 15

RoboIndex

63.8

Down 0.5 since the 2 Nov ranking

Rank change

No change

Now #4 of 38 in Exoskeleton · See the board →

Self-balancing robotic exoskeletons and humanoid robots

Watch Wandercraft robots at work

1 video

ATALANTE X : Changing the paradigm of care · Atalante X

Is this your company? Claim it, free. Fix your record, add videos, see who looks.

Claim Wandercraft

Money and customers

Raised

US$138M

Last raise · Series D · Jun 2025

Customers

1

1 L1 Announced

Is something wrong?

What the score is made of

How it works
Robots 65%54Range 5%53Activity93Press100ReadinessNot yet on fileProof 30%70

The score is 65% robots, 30% proof from customers and the press, 5% range of robots. Activity and readiness are shown for context.

Backed by

+12 more on record.

FUNDING ROUNDS AND CUSTOMERS BY ROBOT

Bigger dot = bigger round. Hollow = amount not disclosed.

Funding rounds

Rounds recorded from January 2017. Every amount links to its source.

Suggest an edit

Customers

1 named customer · 1 L1 Announced. See the names

2 more customers cited in public sources

Suggest an edit

Wandercraft is a French robotics company that develops self-balancing exoskeletons for rehabilitation and personal mobility, including Atalante X and Eve, and humanoid robots such as Calvin-40 for industrial tasks. It operates from France and has expanded commercialization efforts in the United States through partnerships and clinical programs.

Active products

3

Company facts

HQ
Paris, France
Founded
2012 · 14 yrs
Stage
Series D

Active robots by Wandercraft

3 shown
  • 1

    Surgical / Medical · 2022 · Not yet on file

  • 2
    Eve53.5

    Exoskeleton · 2020 · Not yet on file

  • 3

    Exoskeleton · 2025 · Not yet on file

In the news

6 events · last 90 days

+5.0news bonus
  • Oct 20Wandercraft targets global humanoid robotics leadership with 350 robots planned for Renault
  • Oct 1Wandercraft Acquires Ekso Bionics from ChronoScale to Form World's Largest Medical Exoskeleton Powerhouse
  • Sep 30Meet Wandercraft’s Eve: The Self-Balancing Exoskeleton

Why Wandercraft has been in the news, across 12 outlets, collected and classified independently, so a maker cannot add to it. It never changes a robot's RoboScore (the evidence half of the RoboIndex) and it can move a robot up a board by at most 15 points.

Safety reports

Consumer product alerts from this country reach the EU Safety Gate, which we read. Industrial, workplace and medical incidents never enter it, so a blank record says nothing about those.

How this record was collected, register by register

Press coverage

Milestones

  1. Series D: raised US$75.0M

  2. 2025partnershipwandercraft.eu ↗

    Announced Calvin-40, an industrial humanoid robot, alongside a strategic partnership with Renault Group.

  3. Closed a $75 million Series D financing round.

  4. Started clinical trials of the Personal Exoskeleton Eve.

  5. 2024launcheu.36kr.com ↗

    Atalante X received FDA approval for spinal cord injury rehabilitation.

  6. 2023launcheu.36kr.com ↗

    Atalante X was approved by the FDA for stroke rehabilitation.

  7. 2023partnershiprobotsguide.com ↗

    Began commercial operations in the United States through a partnership with Kessler Foundation.

  8. Series C: raised US$45.0M

  9. 2022launch

    Launched Atalante X

  10. 2020launch

    Launched Eve

  11. Series B: raised US$18.0M

Where will these robots operate? Often the same as your country — add more for multi-country deployments.

Exoskeleton buying guides

Industry Knowledge →

People also compare

Similar companies